EAM Global Investors’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-164,511	Closed	-$1.05M	–	169
2018 Q2	$1.05M	Sell	164,511 -62,552	-28%	-$398K	0.51%	122
2018 Q1	$1.08M	Buy	+227,063	New	+$1.08M	0.56%	96